UBS AM’s Fulgent Genetics FLGT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.61M | Buy |
101,303
+1,007
| +1% | +$21.9K | ﹤0.01% | 2140 |
|
|
2025
Q4 | $2.63M | Buy |
100,296
+42,953
| +75% | +$1.11M | ﹤0.01% | 1767 |
|
|
2025
Q3 | $1.3M | Sell |
57,343
-44,495
| -44% | -$916K | ﹤0.01% | 1918 |
|
|
2025
Q2 | $2.02M | Buy |
101,838
+34,782
| +52% | +$678K | ﹤0.01% | 2133 |
|
|
2025
Q1 | $1.13M | Buy |
67,056
+16,402
| +32% | +$279K | ﹤0.01% | 2254 |
|
|
2024
Q4 | $936K | Buy |
50,654
+5,986
| +13% | +$117K | ﹤0.01% | 2389 |
|
|
2024
Q3 | $971K | Buy |
44,668
+5,898
| +15% | +$132K | ﹤0.01% | 2412 |
|
|
2024
Q2 | $761K | Buy |
38,770
+15,301
| +65% | +$319K | ﹤0.01% | 2494 |
|
|
2024
Q1 | $509K | Buy |
23,469
+3,285
| +16% | +$81.6K | ﹤0.01% | 2280 |
|
|
2023
Q4 | $584K | Hold |
20,184
| – | – | ﹤0.01% | 2269 |
|
|
2023
Q3 | $540K | Buy |
20,184
+1,945
| +11% | +$66.4K | ﹤0.01% | 2262 |
|
|
2023
Q2 | $569K | Hold |
18,239
| – | – | ﹤0.01% | 2270 |
|
|
2023
Q1 | $569K | Sell |
18,239
-5,057
| -22% | -$163K | ﹤0.01% | 2270 |
|
|
2022
Q4 | $694K | Buy |
23,296
+2,572
| +12% | +$92K | ﹤0.01% | 2038 |
|
|
2022
Q3 | $790K | Sell |
20,724
-745
| -3% | -$37.3K | ﹤0.01% | 2104 |
|
|
2022
Q2 | $1.17M | Sell |
21,469
-4,416
| -17% | -$243K | ﹤0.01% | 1869 |
|
|
2022
Q1 | $1.62M | Buy |
25,885
+231
| +0.9% | +$15.2K | ﹤0.01% | 1901 |
|
|
2021
Q4 | $2.58M | Buy |
25,654
+5,669
| +28% | +$498K | ﹤0.01% | 1753 |
|
|
2021
Q3 | $1.8M | Sell |
19,985
-4,134
| -17% | -$376K | ﹤0.01% | 1885 |
|
|
2021
Q2 | $2.22M | Buy |
24,119
+3,056
| +15% | +$244K | ﹤0.01% | 1796 |
|
|
2021
Q1 | $2.04M | Sell |
21,063
-137
| -0.6% | -$14.1K | ﹤0.01% | 1734 |
|
|
2020
Q4 | $1.1M | Buy |
+21,200
| New | +$886K | ﹤0.01% | 1939 |
|
Other funds holding FLGT
RI
VCM
ICM
